Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RORC | P51449 | 14/20 | 0.65 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.39 |
| ▸ | PPARG | P37231 | 1/20 | 0.39 |
| ▸ | P2RX7 | Q99572 | 1/20 | 0.38 |
| ▸ | MRGPRX4 | Q96LA9 | 1/20 | 0.38 |
| ▸ | PLA2G4A | P47712 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19360303 | 0.89 | RORC (0.64) | RORCEPHX2PPARGP2RX7 | |
| SCHEMBL19360574 | 0.89 | RORC (0.65) | RORCPPARGMRGPRX4 | |
| SCHEMBL19360368 | 0.88 | RORC (0.63) | RORCEPHX2PPARG | |
| SCHEMBL19360326 | 0.83 | RORC (0.49) | RORCEPHX2PPARG | |
| SCHEMBL20822477 | 0.81 | RORC (0.52) | RORCEPHX2PPARGP2RX7MRGPRX4 | |
| SCHEMBL19360581 | 0.80 | RORC (0.53) | RORCEPHX2P2RX7MRGPRX4 | |
| SCHEMBL19360549 | 0.80 | RORC (0.49) | RORCEPHX2PPARGMRGPRX4 | |
| SCHEMBL19360363 | 0.78 | RORC (0.65) | RORCPPARG | |
| SCHEMBL19360379 | 0.78 | RORC (0.65) | RORC | |
| SCHEMBL19360575 | 0.78 | RORC (0.65) | RORCMRGPRX4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-107531679-B | Aromatic amide derivative, preparation method and medical application thereof | 江苏恒瑞医药股份有限公司 | 2021-07-02 | — | — | CN | disclosed |
| WO-2017157332-A1 | AROMATIC AMIDE DERIVATIVE, PREPARATION METHOD THEREFOR, AND PHARMACEUTICAL APPLICATIONS THEREOF | 江苏恒瑞医药股份有限公司 | 2017-09-21 | — | — | WO | disclosed |